5th EACTS Mechanical Circulatory Support Summit

The 5th EACTS Mechanical Circulatory Support Summit will run from 4-6 November 2021 in Berlin, Germany. THURSDAY 4 NOVEMBER (08:00-18:15) 08:00 Welcome 08:15 Session 1: Current status of heart failure therapy Heart failure therapy: Update on new drugs and devices Current organ allocation in Spain Current organ allocation in Eurotransplant Current organ allocation in UNOS … Continue reading "5th EACTS Mechanical Circulatory Support Summit"

The 5th EACTS Mechanical Circulatory Support Summit will run from 4-6 November 2021 in Berlin, Germany.

THURSDAY 4 NOVEMBER (08:00-18:15)
08:00 Welcome
08:15 Session 1: Current status of heart failure therapy
Heart failure therapy: Update on new drugs and devices
Current organ allocation in Spain
Current organ allocation in Eurotransplant
Current organ allocation in UNOS
SARS-CoV-2 myocarditis and the general impact of the pandemic on advanced heart failure therapy (MCS – HTX)
Short and long-term mechanical circulatory support: What are the challenges for the next decade?
Panel discussion
10:00 Break
10:30 EACTS MCS Lifetime Recognition Award
10:45 Session 2: Update on guidelines and registries
Proposal for short-term MCS guidelines
Update on the ISHLT MCS guidelines
Update on the ESC heart failure guidelines
EUROMACS report
Panel discussion
Featured lecture: Lessons from space
12:15 Lunch
13:15 Session 3: Paediatric MCS
Paediatric myocardial recovery transatlantic network
Challenges in long-term paediatric MCS: Differences to adult patients
MCS or transplant
MCS in GUCH population: Surgical technical considerations
Panel discussion
14:45 Session 4: The perioperative setting
Preimplant optimization
My approach is less invasive
Sternotomy is my preferred access
Off-pump LVAD implantation is my preferred approach
On-pump LVAD implantation is my preferred approach
Panel discussion
16:15 Break
16:45 Session 5: Rehabilitation after MCS
Physical exercise in space: Lessons to learn for the critically ill ICU patient
Nutritional and physical status in VAD candidates: Impact on long-term outcomes
Frailty in end-stage heart failure: Impact on long-term outcomes
Psychological/social rehabilitation after VAD implantation
Panel discussion
18:15 Close
Welcome reception and poster session (18:15-19:30)
FRIDAY 5 NOVEMBER (08:00-18:00)
08:00 Session 6: Valvular disease in long-term MCS
How to prevent secondary aortic valve regurgitation in LVAD patients
Secondary aortic valve replacement in ongoing LVAD therapy: Indications and outcomes
TAVR for secondary aortic valve regurgitation
Interventional mitral valve procedures on LVAD
When to approach tricuspid valve regurgitaion at LVAD implantation
Panel discussion
09:30 Session 7: Challenges in long-term support (Case oriented)
Clinical course of COVID-19 in LVAD patients
Device infections
Thromboembolic events
Graft occlusion
Right ventricular heart failure
Management of implantable cardiac devices in LVAD patients
Panel discussion
10:40 Break
11:00 Session 8: Unusual cases and creative solutions
Case presentation 1
Case presentation 2
Case presentation 3
Case presentation 4
Case presentation 5
Panel discussion
12:30 5th Rising Stars Quiz
13:30 Lunch
14:30 Session 9: LVAD Masterclass
Management of severe acquired coagulopathy
Optimized management for INTERMACS I patients
Different surgical approaches – impliances for cardiac anesthesia
Standardized transesophageal echocardiography for LVAD surgery
Panel discussion
15:35 Session 10: Long-term support
Cardiac comorbidity in LVAD patients and their influence on long-term outcomes
Key to success in ultra long-term LVAD support: Ideal patient characteristics
Treatment of arrhythmias in LVAD patients
Will VAD therapy replace heart transplantation?
Panel discussion
16:30 Break
16:50 Session 11: Short-term MCS and cardiogenic shock
Device selection
Timing in short-term MCS: When is it too early, when is it too late?
Combined algorithm for implantation and weaning of temporary MCS
Transition from termporary to durable MCS
Transplant following ECLS
Panel discussion
18:00 Close
SATURDAY 6 NOVEMBER (08:00-14:00)
08:00 Session 12: Right ventricular heart failure
Pathophysiolgy of right ventricular failure in LVAD therapy and patients selection for biventricular support
Less invasive implantation = less right ventricular failure?
Extracorporeal RVAD in acute right ventricular failure
Percutaneous RVAD in LVAD patients
Chronic right heart failure: Myth or reality
Panel discussion
09:00 Session 13: EACTS heart failure session
10:00 Break
10:30 Session 14: Challenges in ongoing VAD therapy – Different centre, different approach
Pump thrombosis: VAD exchange or lysis?
Optimized heart failure therapy in VAD patients
Surgical options for VAD infections
Bacteriophages in VAD related infections
Panel discussion
11:30 Session 15: Future of VAD management
The fully implantable device
Indications and interactions with other medical devices
Hemodynamic guidance with remote monitoring sensor for pulmonary pressure in VAD therapy
The intelligent VAD: Future perspectives
Panel discussion
12:30 Session 16: Update of current and upcoming devices
Keynote lecture: Innovations in heart failure therapy
13:00 VAD Café: Ask the Industry
14:00 Closing Remarks

 

Programme subject to change

Summit INFORMATION

Date/Duration
4-6 November 2021 (2.5 day course)

Location
Berlin, Germany

Chairmen
J Gummert, Bad Oeynhausen; V Falk, Berlin and I Netuka, Prague

Registration Fee
To be announced

Summit Format
Interactive lectures, live-in-a-box cases and keynote presentations

Target Audience
Cardiologists, heart failure cardiologists, emergency and ICU specialists (ECLS), cardiac surgeons, perfusionists, heart failure nurses and ventricular assist device (VAD) coordinators, medical industry (cardiac devices including ECMO development and production). Paediatric cardiologists and congenital heart disease surgeon.

Please click here for the EACTS Academy terms and conditions.